Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man
- 1 January 1988
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (1) , 93-96
- https://doi.org/10.1016/0006-2952(88)90758-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The warfarin-sulfinpyrazone interaction: stereochemical considerationsClinical Pharmacology & Therapeutics, 1986
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985
- Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.British Journal of Clinical Pharmacology, 1984
- Pharmacokinetics of (+)‐, (‐)‐ and (+/‐)‐verapamil after intravenous administration.British Journal of Clinical Pharmacology, 1984
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacologyEuropean Journal of Clinical Pharmacology, 1984
- Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.Published by Wiley ,1981
- Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatmentJournal of Molecular Medicine, 1980
- Stereoselective Interaction of Phenylbutazone with [12C/13C]Warfarin Pseudoracemates in ManJournal of Clinical Investigation, 1980
- Physiological disposition of verapamil in manCardiovascular Research, 1976